chrysamine g has been researched along with Alzheimer Disease in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Gur, TL; Hou, C; Kung, HF; Kung, MP; Lee, VM; Plössl, K; Skovronsky, DM; Trojanowski, JQ; Zhuang, ZP | 1 |
Gur, T; Hou, C; Kung, HF; Kung, MP; Lee, CW; Lee, VM; Plössl, K; Skovronsky, D; Trojanowski, JQ; Zhuang, ZP | 1 |
Choi, SR; Kung, HF; Qu, W; Skovronsky, D; Zhang, W | 1 |
Choe, YS; Lee, I; Lee, JH; Yang, J | 1 |
Gupta, S; Kumar, S; Modi, G; Rai, H; Ran, C; Singh, SK; Yang, J | 1 |
Ambegaokar, SS; Begum, AN; Chen, PP; Cole, GM; Frautschy, SA; Glabe, CG; Kayed, R; Lim, GP; Simmons, MR; Ubeda, OJ; Yang, F | 1 |
Debnath, ML; Klunk, WE; Koros, AM; Pettegrew, JW | 1 |
Bormans, GM; de Groot, TJ; Dezutter, NA; Dom, RJ; Verbruggen, AM | 1 |
1 review(s) available for chrysamine g and Alzheimer Disease
Article | Year |
---|---|
Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Fluorescent Dyes; Humans; Precision Medicine; tau Proteins | 2022 |
7 other study(ies) available for chrysamine g and Alzheimer Disease
Article | Year |
---|---|
Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoradiography; Benzene Derivatives; Blood-Brain Barrier; Brain; Down Syndrome; Humans; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Kinetics; Ligands; Mice; Peptide Fragments; Structure-Activity Relationship; Styrenes; Thiazoles; Tissue Distribution | 2001 |
Isomerization of (Z,Z) to (E,E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Fluorescent Dyes; Humans; Kinetics; Microscopy, Fluorescence; Peptide Fragments; Plaque, Amyloid; Stereoisomerism; Structure-Activity Relationship; Styrenes | 2001 |
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Fluorine Radioisotopes; Humans; Plaque, Amyloid; Positron-Emission Tomography; Pyridines; Stilbenes; Styrenes; Tissue Distribution | 2010 |
Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Curcumin; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Humans; Mice; Mice, Transgenic; Peptide Fragments; Permeability; Plaque, Amyloid; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2011 |
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Benzothiazoles; Biphenyl Compounds; Blood-Brain Barrier; Brain; Cell Line, Tumor; Congo Red; Curcumin; Diamines; Humans; Ibuprofen; Mice; Mice, Transgenic; Naproxen; Peptide Fragments; Plaque, Amyloid; Protein Binding; Protein Denaturation; Protein Structure, Quaternary; Pyridazines; Solubility; Thiazoles | 2005 |
Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzoates; Biphenyl Compounds; Coloring Agents; Congo Red; Drug Antagonism; Humans; PC12 Cells; Rats | 1998 |
99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzoates; Biphenyl Compounds; Brain; Coloring Agents; Female; Humans; Isotope Labeling; Male; Mice; Mice, Inbred Strains; Middle Aged; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium; Tissue Distribution | 1999 |